{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:25:34Z","timestamp":1762298734782,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008985","name":"Deutsche Morbus Crohn\/Colitis Ulcerosa Vereinigung","doi-asserted-by":"publisher","award":["Ludwig-Demling-Forschungspreis 2015"],"award-info":[{"award-number":["Ludwig-Demling-Forschungspreis 2015"]}],"id":[{"id":"10.13039\/501100008985","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40348-018-0079-0","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T16:17:17Z","timestamp":1516378637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis"],"prefix":"10.1186","volume":"5","author":[{"given":"Teresa","family":"Schleker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Maria","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Michael","family":"Debatin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9487-8812","authenticated-orcid":false,"given":"Carsten","family":"Posovszky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,19]]},"reference":[{"issue":"5","key":"79_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2165\/00148581-200608050-00002","volume":"8","author":"PA Rufo","year":"2006","unstructured":"Rufo PA, Bousvaros A (2006) Current therapy of inflammatory bowel disease in children. Paediatr Drugs 8(5):279\u2013302","journal-title":"Paediatr Drugs"},{"issue":"7","key":"79_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/MEG.0b013e328353750c","volume":"24","author":"C Della Corte","year":"2012","unstructured":"Della Corte C, Sartorelli MR, Sindoni CD, Girolami E, Giovannelli L, Comparcola D et al (2012 Jul) Autoimmune hepatitis in children: an overview of the disease focusing on current therapies. Eur J Gastroenterol Hepatol 24(7):739\u2013746","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"79_CR3","unstructured":"Schleker T, Speth F, Posovszky C (2015\/2016) Impfen beim immunsupprimierten Kind. p\u00e4diatrische praxis. 85:363\u2013384"},{"key":"79_CR4","unstructured":"Robert Koch Institut (2012) Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2010. Epidemiologisches Bulletin 16:135-139"},{"issue":"12","key":"79_CR5","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/ibd.22950","volume":"18","author":"G Cullen","year":"2012","unstructured":"Cullen G, Baden RP, Cheifetz AS (2012 Dec) Varicella zoster virus infection in inflammatory bowel disease. Inflamm Bowel Dis 18(12):2392\u20132403","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"79_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","volume":"8","author":"JF Rahier","year":"2014","unstructured":"Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y et al (2014) Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn\u2019s Colitis 8(6):443\u2013468","journal-title":"J Crohn\u2019s Colitis"},{"key":"79_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/B978-1-4160-3611-1.50006-4","volume":"5","author":"C Siegrist","year":"2008","unstructured":"Siegrist C (2008) Vaccine immunology. Vaccine 5:17\u201336","journal-title":"Vaccine"},{"issue":"3","key":"79_CR8","first-page":"228","volume":"12","author":"AK Shetty","year":"2012","unstructured":"Shetty AK, Winter MA (2012) Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation. Ochsner J 12(3):228\u2013243","journal-title":"Ochsner J"},{"issue":"10","key":"79_CR9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/ard.2011.150193","volume":"70","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Kone-Paut I et al (2011 Oct) EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis 70(10):1704\u20131712","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"79_CR10","first-page":"168","volume":"78","author":"LA Nafe","year":"2014","unstructured":"Nafe LA, Dodam JR, Reinero CR (2014 Jul) In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay. Can J Vet Res 78(3):168\u2013175","journal-title":"Can J Vet Res"},{"issue":"1","key":"79_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-1759(01)00369-6","volume":"253","author":"MJ Barten","year":"2001","unstructured":"Barten MJ, Gummert JF, van Gelder T, Shorthouse R, Morris RE (2001) Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. J Immunol Methods 253(1):95\u2013112","journal-title":"J Immunol Methods"},{"issue":"3","key":"79_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/sji.12081","volume":"78","author":"R Dahl\u00e9n","year":"2013","unstructured":"Dahl\u00e9n R, Strid H, Lundgren A, Isaksson S, Raghavan S, Magnusson MK et al (2013) Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis. Scand J Immunol 78(3):275\u2013284","journal-title":"Scand J Immunol"},{"issue":"6","key":"79_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/annrheumdis-2011-201270","volume":"72","author":"GF Salinas","year":"2013","unstructured":"Salinas GF, De Rycke L, Barendregt B, Paramarta JE, Hreggvidstdottir H, Cantaert T et al (2013 Jun) Anti-TNF treatment blocks the induction of T cell-dependent humoral responses. Ann Rheum Dis 72(6):1037\u20131043","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"79_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2008.11.003","volume":"131","author":"KD Stone","year":"2009","unstructured":"Stone KD, Feldman HA, Huisman C, Howlett C, Jabara HH, Bonilla FA (2009) Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency. Clin Immunol 131(1):41\u201349","journal-title":"Clin Immunol"},{"issue":"4","key":"79_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S0091-6749(99)70294-0","volume":"104","author":"SE Pacocha","year":"1999","unstructured":"Pacocha SE, Oriente A, Huang S, Essayan DM (1999) Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists. J Allergy Clin Immunol 104(4):828\u2013835","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"79_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00007890-199204000-00031","volume":"53","author":"MB Teunissen","year":"1992","unstructured":"Teunissen MB, Pistoor FH, Rongen HA, Kapsenberg ML, Bos JDA (1992 Apr) Comparison of the inhibitory effects of immunosuppressive agents cyclosporine, tetranactin, and didemnin B on human T cell responses in vitro. Transplantation 53(4):875\u2013881","journal-title":"Transplantation"},{"issue":"3","key":"79_CR17","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0022-3565(24)35215-2","volume":"291","author":"JF Gummert","year":"1999","unstructured":"Gummert JF, Barten MJ, Sherwood SW, van Gelder T, Morris RE (1999 American Society for Pharmacology and Experimental Therapeutics) Pharmacodynamics of Immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J Pharmacol Exp Ther 291(3):1100\u20131112","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"79_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/08923978309026448","volume":"5","author":"JO Cook","year":"1983","unstructured":"Cook JO, Lai W, McGrane B (1983) The effect of suboptimal concentrations of mitogens on the immunosuppressive action of azathioprine and prednisolone on human lymphocytes in vitro. J Immunopharmacol 5(4):257\u2013275","journal-title":"J Immunopharmacol"},{"issue":"3","key":"79_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/0090-1229(86)90186-8","volume":"40","author":"E Dupont","year":"1986","unstructured":"Dupont E, Schandene L, Denys C, Wybran J (1986) Differential in vitro actions of cyclosporin, methylprednisolone, and 6-mercaptopurine: implications for drugs\u2019 influence on lymphocyte activation mechanisms. Clin Immunol Immunopathol 40(3):422\u2013428","journal-title":"Clin Immunol Immunopathol"},{"issue":"8","key":"79_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2460\/ajvr.2000.61.906","volume":"61","author":"AE Kyles","year":"2000","unstructured":"Kyles AE, Gregory CR, Craigmill AL (2000 Aug) Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats. Am J Vet Res 61(8):906\u2013909","journal-title":"Am J Vet Res"},{"issue":"9","key":"79_CR21","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","volume":"35","author":"E Croce","year":"2017","unstructured":"Croce E, Hatz C, Jonker EF, Visser LG, Jaeger VK, B\u00fchler S (2017) Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation\u2014a systematic review of randomized trials, observational studies and case reports. Vaccine 35(9):1216\u20131226","journal-title":"Vaccine"},{"key":"79_CR22","doi-asserted-by":"publisher","unstructured":"Edwards A, Gao Y, Allan RN, Ball D, de Graaf H, Coelho T, et al. Corticosteroids and infliximab impair the performance of interferon-\u03b3 release assays used for diagnosis of latent tuberculosis. Thorax. 2017 BMJ Publishing Group Ltd and British Thoracic Society 72(10). Local EPrints ID: 405831. URL: http:\/\/eprints.soton.ac.uk\/id\/eprint\/405831 , https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209397","DOI":"10.1136\/thoraxjnl-2016-209397"}],"container-title":["Molecular and Cellular Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40348-018-0079-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-018-0079-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-018-0079-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T23:01:57Z","timestamp":1751238117000},"score":1,"resource":{"primary":{"URL":"https:\/\/molcellped.springeropen.com\/articles\/10.1186\/s40348-018-0079-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,19]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["79"],"URL":"https:\/\/doi.org\/10.1186\/s40348-018-0079-0","relation":{},"ISSN":["2194-7791"],"issn-type":[{"type":"electronic","value":"2194-7791"}],"subject":[],"published":{"date-parts":[[2018,1,19]]},"assertion":[{"value":"27 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The presented data is part of the VARICED\u00a0vaccination observational\u00a0study.\u00a0The VARICED study is approved by the ethical board of ethics committee, University of Ulm, under the number 214\/2013. Written consent of each participant or legal parent or guardian was received before the study inclusion including the scientific evaluation of the data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1"}}